Boston
,
USA
1 - 4 June 2024
Endocrine Society 2024 (ENDO 2024)
Presentation schedule and materials
Saturday, 01 June 2024
12:15
- 13:45
EDT
SAT-694
POSTER
Long-Term Effectiveness and Safety of GH Replacement Therapy in Adults Aged＜60 Years: Real-World Data From NordiNet® IOS and ANSWER
John D. Carmichael1; Atil Y. Kargi2; Laura Dichtel3; Nicky Kelepouris4; Navid Nedjatian5; Moshe Fridman6; Matthias M. Weber7
12:15
- 13:45
EDT
7265
POSTER
Characterization of Treatment Intensified (Add-on to Metformin) Adults With Type 2 Diabetes Mellitus in Thailand: A Cross-Sectional Real-World Study (CONVERGE)
Chutintorn Sriphrapradang, MD1; Ratiporn Chinthammit, BSc, MSc2; Gurudutt Nayak, MD2
Sunday, 02 June 2024
12:00
- 13:30
EDT
SUN-704
POSTER
Evaluating the Device Handling and Preference Assessment Questionnaire for Growth Hormone Deficiency: A Cognitive Debriefing Study
Jesper Skov Neergaard1; Shahid Akhtar1; Birgitte Berg1; Sophie Hamilton2; Emily Hildebrand3; Johan Medin1; Gitte Ter-Borch1; Niklas Kahr Rasmussen1
Monday, 03 June 2024
12:00
- 13:30
EDT
MON-703
POSTER
Pre-treatment Blood Transcriptome Accurately Predicts Growth Response To Daily And Weekly GH Treatment In Children Born Small For Gestational Age
Terence Garner1; Philip Murray2; Michael Hojby3; Ryan Ard3; Peter Ellis Clayton4; Adam Stevens1
12:00
- 13:30
EDT
MON-103
POSTER
Prevalence and Risk Factor of Complications in Patients with Adult Growth Hormone Deficiency: A Retrospective Database Study
Hidenori Fukuoka1; Shingo Fujio2; Takaaki Endo3; Satoshi Tsuboi3
14:30
- 14:45
EDT
OR36-03
ORAL PRESENTATION
Sustained Efficacy of Weekly Somapacitan in Children With GHD: 3-year Results From Phase 3 REAL4 Study
Bradley S. Miller1; Joanne C. Blair2; Michael Højby Rasmussen3; Aristides Maniatis4; Jun Mori5; Volker Böttcher6; Ho-Seong Kim7; Michel Polak8; Reiko Horikawa9
Keywords